Shang Rong Medical has abundant orders in hand. The company currently has an order amount of 5.685 billion (which is subject to the audit settlement price), and the average construction period is 2-3 years. If the project construction progresses smoothly, the settlement of existing orders will strongly support the company's future growth. At the same time, the company has a number of potential projects that have signed a cooperation framework agreement, the overall amount is expected to exceed 7 billion, of which the overall amount of Lanzhou New District and Shangqiu projects are expected to be between 2 billion and 2.5 billion and 3 billion respectively, of which Lanzhou New District already has Chinese medicine hospitals. The construction project (457 million) was successfully landed. The company is likely to obtain two major projects, Lanzhou and Shangqiu, and will strongly support the subsequent development.
The PPP and buyer credit models have accelerated the expansion of hospital construction projects. In order to solve the bottleneck problem faced by some local governments in the process of new hospitals or renovation and expansion, the company launched PPP and buyer credit models. At present, the company has 6 PPP projects in Qinhuangdao, Hebei, Fuping County, Shaanxi, Dushan County and Sandu Shui Autonomous County, Huainan City, Anhui Province, and Jiaxiang County, Shandong Province. Fuping Hospital of Integrated Traditional Chinese and Western Medicine has been put into operation. The company plans to invest 30 hospitals in the PPP model in the next 3-5 years to manage 20,000 beds. The PPP project helps the company manage the hospital supply chain while gaining value-added services and subsequent investment income while developing the company's overall hospital construction project.
The company will raise 840 million yuan to accelerate business development. The company's re-launched fixed-income plan is to issue no more than 80 million shares to raise no more than 840 million for the hospital surgery department, ICU product industrialization project (590 million) and increase the hospital's overall construction business funds (2.5 Billion). Previously, in June 2016, the company issued an additional 5.52 million shares to major shareholders at a price of 23.47 yuan per share, raising 200 million yuan, which provided a security mat for the company's share price.
Internal Secretion,Metformin Hydrochloride,Thioctic Acid Tablets,Sustained Release Tablets
Shandong Qidu Pharmaceutical Co., Ltd. , https://www.qdyypharma.com